Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

NCT04565977 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT04565977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04565977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
June 10, 2021
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercoagulable states